Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

DS-1040 Tosylate

😃Good
Catalog No. T11100Cas No. 1335138-89-0

DS-1040 Tosylate is an oral active, selective thrombolytic inhibitor with IC50s of 5.92 nM and 8.01 nM for human and rat TAFIa, is an orally active, selective inhibitor of activated thrombin-activatable fibrinolysis inhibitor (TAFIa) with IC50s of 5.92 nM and 8.01 nM for human and rat TAFIa. DS-1040 Tosylate is a fibrinolysis enhancer for thromboembolic diseases[1].

DS-1040 Tosylate

DS-1040 Tosylate

😃Good
Catalog No. T11100Cas No. 1335138-89-0
DS-1040 Tosylate is an oral active, selective thrombolytic inhibitor with IC50s of 5.92 nM and 8.01 nM for human and rat TAFIa, is an orally active, selective inhibitor of activated thrombin-activatable fibrinolysis inhibitor (TAFIa) with IC50s of 5.92 nM and 8.01 nM for human and rat TAFIa. DS-1040 Tosylate is a fibrinolysis enhancer for thromboembolic diseases[1].
Pack SizePriceAvailabilityQuantity
2 mg$1195 days
25 mg$6148-10 weeks
50 mg$7988-10 weeks
100 mg$1,3608-10 weeks
Bulk & Custom
Add to Cart
Questions
View More
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
DS-1040 Tosylate is an oral active, selective thrombolytic inhibitor with IC50s of 5.92 nM and 8.01 nM for human and rat TAFIa, is an orally active, selective inhibitor of activated thrombin-activatable fibrinolysis inhibitor (TAFIa) with IC50s of 5.92 nM
Targets&IC50
TAFIa (human):5.92 nM , TAFIa (rat):8.01 nM
In vitro
Ds-1040 Tosylate inhibited human carboxypeptidase N (CPN) in vitro with an IC50 of 3.02 mM.
In vivo
DS-1040 Tosylate (0.0005-0.5 mg/kg; IV) significantly reduces the microthrombi index at doses of 0.005 mg/kg and greater. DS-1040 (0.016-0.50 mg/kg; i.v.) increases plasma D-dimer levels dose-dependently in a microthrombosis model, with ED50 and EDmax of 122 and 221 nmol/L, respectively. Orally administered DS-1040 (0.25-16 mg/kg) also increases plasma D-dimer levels, with EC50 and ECmax values of 114 and 231 nmol/L, respectively.
Chemical Properties
Molecular Weight465.61
FormulaC23H35N3O5S
Cas No.1335138-89-0
Relative Density.no data available
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
H2O: 100 mg/mL (214.77 mM), Sonication is recommended.
Solution Preparation Table
H2O
1mg5mg10mg50mg
1 mM2.1477 mL10.7386 mL21.4772 mL107.3860 mL
5 mM0.4295 mL2.1477 mL4.2954 mL21.4772 mL
10 mM0.2148 mL1.0739 mL2.1477 mL10.7386 mL
20 mM0.1074 mL0.5369 mL1.0739 mL5.3693 mL
50 mM0.0430 mL0.2148 mL0.4295 mL2.1477 mL
100 mM0.0215 mL0.1074 mL0.2148 mL1.0739 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy DS-1040 Tosylate | purchase DS-1040 Tosylate | DS-1040 Tosylate cost | order DS-1040 Tosylate | DS-1040 Tosylate chemical structure | DS-1040 Tosylate in vivo | DS-1040 Tosylate in vitro | DS-1040 Tosylate formula | DS-1040 Tosylate molecular weight